RNF167

Chr 17

ring finger protein 167

Also known as: 5730408C10Rik, LP2254, RING105

RNF167 encodes an E3 ubiquitin ligase that regulates TORC1 signaling, synaptic transmission through AMPAR receptor degradation, and protein trafficking pathways including endosomal recycling and lysosome positioning. Mutations cause autosomal recessive developmental and epileptic encephalopathy with onset in infancy, characterized by severe intellectual disability, refractory seizures, and progressive microcephaly. The gene shows moderate constraint against loss-of-function variants, consistent with the recessive inheritance pattern observed in affected individuals.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.63
Clinical SummaryRNF167
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.32) despite low pLI — interpret in context.
📋
ClinVar Variants
24 unique Pathogenic / Likely Pathogenic· 75 VUS of 119 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.63LOEUF
pLI 0.032
Z-score 2.75
OE 0.32 (0.170.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.04Z-score
OE missense 1.01 (0.901.13)
210 obs / 208.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.32 (0.170.63)
00.351.4
Missense OE1.01 (0.901.13)
00.61.4
Synonymous OE1.13
01.21.6
LoF obs/exp: 6 / 18.9Missense obs/exp: 210 / 208.3Syn Z: -0.94
DN
0.6937th %ile
GOF
0.81top 10%
LOF
0.2582th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

119 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic2
VUS75
Likely Benign2
Benign3
22
Pathogenic
2
Likely Pathogenic
75
VUS
2
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
22
0
22
Likely Pathogenic
0
0
2
0
2
VUS
0
61
14
0
75
Likely Benign
0
1
1
0
2
Benign
1
0
2
0
3
Total162410104

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RNF167 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗